CLINICAL_TRIALS
trial_result
· 2026-06-08
Clinical Trial Results: GI Permeability Change in Response to Aquamin® [Phase 2]
Summary
Phase 2 trial assessing GI permeability changes in response to Aquamin® in Ulcerative Colitis; results completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: James Varani | Conditions: Ulcerative Colitis, Healthy | Phase 2 | Status: COMPLETED | Results posted: 2026-06-08